In contrast, KIF18B demonstrated a significant negative correlation with Tregs in skin cutaneous melanoma (R = -0.19), lymphoid neoplasm diffuse large B-cell lymphoma (R = -0.51), and bladder urothelial carcinoma (R = -0.26) (10). Here, KIF18B is linked to diffuse large B-cell lymphoma.